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Introduction {#sec1}
============

Somatic cells can be successfully induced by forced expression of four key transcription factors into induced pluripotent stem cells (iPSCs) that resemble embryonic stem cells (ESCs) ([@bib45], [@bib54], [@bib58]). The induction efficiency and quality of iPSCs can be significantly improved by various approaches, notably by small molecules ([@bib24], [@bib25], [@bib29], [@bib43]). In combination with small molecules or bone morphogenetic proteins, only Oct4 is needed for generation of iPSCs ([@bib6], [@bib28], [@bib60]). High-content chemical screening has been attempted to achieve a goal of each transgenic factor being replaced with a small molecule that induces reprogramming ([@bib26]). Finally, somatic cells are successfully reprogrammed into pluripotent stem cells (PSCs) by pure small chemicals ([@bib21]). The chemically induced PSCs (CiPSCs) presumably provide an alternative source with greater potential in stem cell-based therapy. Subsequently, two reports demonstrated successful generation of CiPSCs at higher efficiency by pure chemical compounds with slight modification of the recipe ([@bib33], [@bib59]). Nevertheless, the reprogramming by complete chemicals is still at low efficiency and takes much longer than does OSKM-induced reprogramming ([@bib36], [@bib45]).

Telomeres consist of repeated guanine-rich sequences and associated protein complexes known as shelterin that cap the end of chromosomes to maintain genomic stability ([@bib5], [@bib40]). Short telomeres can lead to cell senescence or tumorigenesis ([@bib7]). Sufficiently long telomeres are important for unlimited self-renewal and pluripotency of PSCs ([@bib22], [@bib37]). Short telomeres impair the differentiation capacity of ESCs ([@bib41]). Telomere length is maintained primarily by the ribonucleoprotein telomerase, a complex of a reverse transcriptase encoded by three core components: *Tert* (telomerase reverse transcriptase), template RNA *Terc* (essential RNA component), and *dyskerin* ([@bib40]). Telomerase is strongly expressed and required for telomere maintenance of mouse and human PSCs ([@bib22], [@bib23], [@bib37], [@bib49], [@bib51]). However, it remains elusive whether telomeres are appropriately reprogrammed and sufficiently elongated in CiPSCs.

We attempted to investigate telomere dynamics of CiPSCs generated based on the methods described recently ([@bib33], [@bib59]). We found that CiPSCs acquire telomere lengthening with increasing passages. Surprisingly, telomeres suffer from erosion at late stages during extended periods of chemical induction, limiting reprogramming efficiency. We searched for compounds that can reduce telomere damage and shortening and thus improve chemical reprogramming. Promisingly, histone crotonylation induced by crotonic acid can alleviate telomere damage and shortening, enhancing the chemical induction efficiency.

Results {#sec2}
=======

Generation of CiPSCs {#sec2.1}
--------------------

We attempted to generate CiPSCs following two recently published methods. One used a combination of seven small-molecule compounds ([@bib21]), and bromodeoxyuridine (BrdU) ([@bib33]), herein referred to as the BrdU method. The other requires three stages to complete induction of CiPSCs, which undergo an extra-embryonic endoderm (XEN)-like state as an intermediate, and differs from the pathway of transcription factor-induced reprogramming, so is referred to as the three-step method ([@bib59]). Mouse embryonic fibroblasts (MEFs) were isolated from Oct4-GFP (OG2) transgenic mice harboring a GFP reporter driven by the distal Oct4 promoter and enhancer, activation of which indicates a naive state of pluripotency ([@bib3], [@bib11], [@bib48], [@bib55]). We successfully generated CiPSCs from OG2-MEFs following either the BrdU method (the randomly selected cell lines for further studies were CiPS1b, 3b, and 7b) or three-step method (cell lines named as CiPS2t, 4t, and 6t) ([Figure S1](#mmc1){ref-type="supplementary-material"}A).

Continuous passages of ESC-like primary colonies established stable CiPSC lines that resembled typical ESC colonies in morphology, exhibiting large nuclei and nucleoli and clear compact clonal boundaries and expression of Oct4-GFP ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A), distinct from feeder fibroblasts. Colonies were stochastically picked and six established CiPSC lines chosen for further characterization of their pluripotency. By direct comparison with OG4 ESC lines established simultaneously from syngeneic background ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}), CiPSCs exhibited pluripotency, as shown by expression at similarly high levels of key pluripotency factors OCT4, NANOG, SOX2, and *Rex1*, and surface marker SSEA1 by immunofluorescence microscopy, RT-qPCR, and western blot ([Figures 1](#fig1){ref-type="fig"}B, 1D, and [S1](#mmc1){ref-type="supplementary-material"}C). Expression levels of pluripotency genes did not differ in CiPSCs at various passages (passage 4 \[P4\] to P22), like those of ESCs (OG4) at P4--5. CiPSCs also expressed high alkaline phosphatase activity ([Figure S1](#mmc1){ref-type="supplementary-material"}D).Figure 1Pluripotency and Differentiation Capacity of CiPSCs(A) Representative morphology of CiPSCs generated by two methods (BrdU method, CiPSC1b at P12, and three-step method, CiPSC2t at P10) under bright field (BF) with phase contrast optics and expression of Oct4-GFP fluorescence. Scale bar represents 100 μm.(B) Immunofluorescence microscopy of pluripotent markers SOX2, NANOG, and SSEA1. Scale bar represents 10 μm.(C) mRNA expression levels by qPCR of *Oct4*, *Nanog*, and *Rex1* in CiPSCs at various passages, compared with isogenic ESCs (OG4) and progenitor MEFs. Data represent mean ± SEM from three independent experiments.(D) Protein levels of OCT4, NANOG, and SOX2 by western blot analysis of CiPSCs at earlier and advanced passages.(E) Differentiation capacity *in vitro* of CiPSCs by immunofluorescence microscopy of three germ layer markers. Scale bar represents 10 μm.(F) Left photo represents chimeras generated from the BrdU method and the right from the three-step method.(G) Summary table showing percentage of chimeras generated from CiPSCs at different passages compared with OG4 ESCs. Chimeras (black and albino coat) were initially identified by coat color and some confirmed by microsatellite genotyping. CiPSC1b and 7b were generated using the BrdU method and CiPSC2t and the 6t by three-step method.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

These CiPSCs were able to differentiate into three embryonic germ layers by embryoid body formation *in vitro*, namely ectoderm, mesoderm, and endoderm ([Figure 1](#fig1){ref-type="fig"}E). We also tested the developmental pluripotency *in vivo* by injecting the CiPSCs into four- to eight-cell recipient albino embryos followed by embryo transfer. CiPSC1b and 7b cell lines and CiPSC2t and 6t cell lines at advanced passages efficiently generated chimeras by coat color ([Figures 1](#fig1){ref-type="fig"}F and 1G), but chimeras from these CiPSCs lines (n = 4 for BrdU method, and n = 10 for three-step method) failed to produce germline transmission following breeding with albino ICR mice for more than two rounds. Nevertheless, CiPSCs at earlier passages (P4 or P5) failed to form chimeras ([Figure 1](#fig1){ref-type="fig"}G).

These results validate that the CiPSCs do exhibit pluripotency *in vivo* and differentiation capacity *in vitro*. However, acquisition of developmental pluripotency of CiPSCs depends on the extended passages.

Telomeres of CiPSCs Rejuvenate with Increasing Passages {#sec2.2}
-------------------------------------------------------

To investigate whether telomeres are elongated and associated with pluripotency of CiPSCs with increasing passages, three CiPSC lines generated by either method were analyzed for their telomere lengths at various passages, P4∼P6 (arbitrarily considered as early passages), P10∼P12 (mid passages), and P18∼P22 (late or advanced passages). Key telomerase genes *Terc* and *Tert* were expressed at higher levels in all CiPSC lines than in MEFs, and comparable with those of ESCs regardless of passages ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Higher expression levels of telomerase genes corroborated with higher telomerase activity in CiPSCs compared with MEFs ([Figure 2](#fig2){ref-type="fig"}A). TRF1, *Pot1a/b*, *Rap1*, and *Tin2* components of the shelterin complex to safeguard robust telomeres ([@bib10]) also were upregulated in the CiPSCs ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C).Figure 2Telomere Rejuvenates in CiPSCs with Passages(A) Telomerase activity by telomeric repeat amplification protocol (TRAP) assay of CiPSCs during passages compared with progenitor cell MEFs. Lysis buffer served as negative control and OG4 ESCs as positive control.(B and C) Telomere length distribution shown as TRF by Southern blot analysis of MEFs and CiPSCs following passages.(D) Representative images displaying telomere FISH of MEF and CiPSCs at various passages. Blue, chromosomes stained with DAPI; green dots, telomeres.(E) Line progression plot showing dynamics of relative telomere length by Q-FISH shown as telomere fluorescence unit (TFU) of MEFs and CiPSCs for each cell line from early to late passage. Left, BrdU method; right, three-step method.(F) Scatterplots showing comparison of genome-wide transcription profile between CiPS1b or CiPS2t and ESC (OG4) or MEF. Parallel diagonal lines indicate 2-fold threshold in expression difference. Red, upregulated genes; green, downregulated genes.(G) ZSCAN4 protein levels by western blot analysis. MEF and ESCs (OG4) served as negative and positive controls, respectively. β-ACTIN served as loading control.(H) C-circle assay. Hela and U2OS served as negative and positive controls, respectively.(I) Representative micrographs showing telomere sister chromatid exchange (T-SCE, white arrows) by chromosome orientation FISH analysis.(J) Frequency of T-SCE. n, number of spread counted. ^∗∗∗^p \< 0.001, compared with MEFs. Two independent experiments.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

Moreover, telomeres lengthened gradually in the formed CiPSCs and elongated further with increasing passages, estimated by telomere quantitative fluorescent in situ hybridization (Q-FISH) and also validated by telomere restriction fragment (TRF) analysis ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}D). Interestingly, CiPSCs generated by the BrdU method initially exhibited only minor telomere elongation from P5 to P12, comparable with that of MEFs, but achieved robust telomere elongation by continuous passage and culture to P22 ([Figures 2](#fig2){ref-type="fig"}B, 2E, and [S2](#mmc1){ref-type="supplementary-material"}D). CiPSCs obtained by the three-step method showed longer telomeres at early passage (e.g., P4), relative to those of MEFs, and gradually elongated telomeres from P4 to P18 ([Figure 2](#fig2){ref-type="fig"}C). Telomeres were modestly extended in most CiPSCs at earlier passage CiPSCs (CiPSC1b, 3b, 7b at P5 and CiPSC2t and 6t at P4) in comparison with those of the precursor MEFs, except for one cell line, CiPS4t, that possessed moderately longer telomere at P4 ([Figures 2](#fig2){ref-type="fig"}C, 2E, and [S2](#mmc1){ref-type="supplementary-material"}D). Telomere lengths and the trend in their elongation estimated by the Q-FISH method corresponded with those measured by TRF.

These data suggest that telomeres of somatic cells are rejuvenated in the formed CiPSCs following passage and culture *in vitro*. Achievement of developmental pluripotency of CiPSCs at advanced passages is closely associated with sufficiently elongated telomeres and this also can be suggestive of full reprogramming.

CiPSCs Express Two-Cell Genes, Including *Zscan4* {#sec2.3}
-------------------------------------------------

By RNA-sequencing (RNA-seq) analysis, genome-wide gene expression profile differed remarkably between CiPSCs and MEFs but was similar between CiPSCs and ESCs ([Figure 2](#fig2){ref-type="fig"}F). CiPSCs highly expressed naive state marker genes, such as *Zfp42/Rex1*, *Esrrb*, *Dppa3*, and *Prdm14*, like ESCs ([@bib39], [@bib50]) ([Figure 2](#fig2){ref-type="fig"}F). Furthermore, CiPSCs expressed *Zscan4* at higher levels but *Twist2*, *Thy1*, and *Fbn1* genes for lineage differentiation at lower levels, in contrast to MEFs ([Figure 2](#fig2){ref-type="fig"}F). *Zscan4* and other 2C-genes, including *MuERVL*, *Tcstv1*, and *Tcstv3*, were expressed at similarly high levels in CiPSCs and ESCs in contrast to MEFs ([Figures 2](#fig2){ref-type="fig"}F, 2G, and [S2](#mmc1){ref-type="supplementary-material"}E). Proportion of Zscan4^*+*^ cells was comparable in CiPSCs and ESCs (P15) by both immunofluorescence microscopy and flow cytometry ([Figures S2](#mmc1){ref-type="supplementary-material"}F--S2H). *Zscan4* and *MuERVL* are expressed specifically in two-cell (2C) embryos and transiently in sporadic ESCs (1%--5%) at any given time, marking a transient 2C state of mouse ESCs ([@bib34], [@bib56]). Telomeres lengthen rapidly in 2C embryos and ZSCAN4 elongates telomeres promptly by recombination-based mechanisms and maintains genomic stability ([@bib31], [@bib56]).

The single-stranded telomeric (CCCTAA)n DNA circles (C-circles) assay detects recombination-based alternative lengthening of telomeres (ALT) ([@bib17], [@bib18]). We showed that C-circle levels were high in CiPSCs and ESCs, comparable with U2OS serving as ALT control, but low or minimal in Hela as negative controls, and in MEFs ([Figure 2](#fig2){ref-type="fig"}H). In addition, telomere sister chromatid exchange (T-SCE) has been implicated as telomere recombination-based ALT ([@bib2], [@bib4], [@bib31], [@bib32], [@bib56]). Like iPSCs generated by the conventional induction method ([@bib51]), CiPSC lines also displayed increased frequency of T-SCE at a level similar to that of ESCs, in contrast to MEFs ([Figures 2](#fig2){ref-type="fig"}I and 2J). These data suggest that the telomere recombination-based ALT mechanism is involved in telomere elongation of CiPSCs.

Although telomerase is activated earlier during induction, it is unclear whether levels of telomerase activity indeed influence induction of CiPSCs. To understand this, we attempted to generate CiPSCs using a three-step method from telomerase *Terc*-deficient (knockout, *Terc*^−/−^) MEFs, compared with heterozygous (HT) *Terc*^+/−^ and wild-type (WT) MEFs. CiPSC primary colonies were obtained, and the efficiency of induction did not differ among *Terc*^−/−^, *Terc*^+/−^, and WT MEFs, based on alkaline phosphatase activity assay ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). These data suggest that telomerase is dispensable for induction of CiPSCs. Despite lack or haploinsufficiency of telomerase activity, these CiPSCs still expressed pluripotency genes (e.g., *Oct4*, *Sox2*, *Nanog*, *Zscan4*, and SSEA1) at high levels, as did WT CiPSCs ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3G). However, the telomerase-deficient CiPSCs showed telomere shortening, telomere loss, and chromosomal fusions, compared with WT CiPSCs generated simultaneously ([Figures S3](#mmc1){ref-type="supplementary-material"}H and S3I), indicating that telomerase is essential for telomere maintenance of CiPSCs. This is also consistent with human iPSC induction, where telomerase gene mutation causes telomere shortening during induction, but activation of telomerase *TERC* by OCT4 acquires telomere rejuvenation and maintenance during passages after iPSC formation ([@bib1]). Collectively, telomeres rejuvenate in CiPSCs following culture *in vitro* by passaging. Both telomerase and telomere recombination-based mechanism are required for telomere elongation in CiPSCs, like ESCs.

CiPSCs with Longer Telomeres Exhibit Higher Differentiation Potential {#sec2.4}
---------------------------------------------------------------------

Sufficiently elongated telomeres may indicate the achievement of full reprogramming and differentiation capacity of CiPSCs. To test whether telomere lengths indicate differentiation capacity of CiPSCs *in vivo*, we performed a teratoma formation test by injection of CiPSCs at early and advanced passages under the skin of immunodeficient mice ([@bib35]). CiPSCs derived by either the BrdU or three-step method had comparatively short telomeres at early passages, slightly longer than those of progenitor cells, and achieved longer telomeres at relatively late passages ([Figures 2](#fig2){ref-type="fig"}B--2E). Remarkably, teratomas derived from CiPSCs at late passages with longer telomeres were larger and heavier than those of CiPSCs at early passages with shorter telomeres ([Figures 3](#fig3){ref-type="fig"}A and 3B). Linear regression analysis showed high correlation between telomere length and teratoma weight of CiPSCs (R^2^ = 0.662 for BrdU method and R^2^ = 0.526 for three-step method) ([Figure 3](#fig3){ref-type="fig"}C).Figure 3Telomere Length Indicates Differentiation Capacity by Teratoma Formation(A) Differentiation *in vivo* of CiPSCs at early and late passages by teratoma formation test.(B) Weight of teratomas formed from CiPSCs, Mean ± SEM (n = 6 mice). ^∗^p \< 0.05, ^∗∗^p \< 0.01.(C) Linear regression analysis showing high correlation between telomere length (TFU by Q-FISH) and teratomas weight of CiPSCs.(D) Histology by H&E staining of teratoma tissues derived from early and late passage CiPSCs. Scale bar represents 50 μm.(E) Immunofluorescence of the teratomas showing markers representative of three germ layers: NESTIN (ectoderm), SMA (mesoderm), and AFP (endoderm). Scale bar represents 100 μm.

Moreover, although the representative three embryonic germ layers, including epidermis and neural ectoderm, muscle (mesoderm), and gland epithelium (endoderm), were found in the teratomas formed from CiPSCs, the structures of the characteristic germ layers generally were smaller from CiPSCs at early passages than those of CiPSCs at late passages ([Figure 3](#fig3){ref-type="fig"}D). Immunofluorescence microscopy further validated that these teratomas expressed molecular markers representative of three germ layers, including NESTIN (ectoderm), smooth muscle actin (SMA) (mesoderm), and alfa-fetoprotein (AFP) (endoderm). However, these germ layers developed more extensively in teratomas formed from CiPSCs at late passages than did those at early passages ([Figure 3](#fig3){ref-type="fig"}E). Hence, by both histology and immunofluorescence microscopy, CiPSCs that acquire telomere lengthening and longer telomeres show higher differentiation potential *in vivo*.

Telomere Shortening during Late Stage of Lengthy Induction by Small Molecules {#sec2.5}
-----------------------------------------------------------------------------

To understand telomere changes during long period of chemical induction, we collected cell samples on days 0 (MEFs), 15, 30, and 40 and compared them with CiPSCs at early passage, which served as positive control, and analyzed expression of genes important for pluripotency and telomerase, telomerase activity, and telomere lengths. Formation of the primary CiPSC colonies can be obtained 40 days after induction by complete small molecules, consistent with previous reports ([@bib33], [@bib59]). The MEFs emerged as aggregates and achieved a XEN-like state by expression of marker genes *Gata4*, *Gata6*, and *Sall4* 15 days following induction ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A), in agreement with the findings that the chemical reprogramming process requires the early formation of XEN-like cells ([@bib59]). By the BrdU method, mRNA levels of *Oct4*, *Sox2*, and *Zscan4* slightly increased by days 30 and 40, and *Nanog* was not readily detectable. By the three-step method, *Oct4*, *Sox2*, *Nanog*, and *Zscan4* were expressed at variable levels but much lower than those of the formed CiPSCs ([Figure 4](#fig4){ref-type="fig"}B). Western blot confirmed that protein levels of OCT4, NANOG, SOX2, and ZSCAN4 were minimal or undetectable during induction, in contrast to the formed CiPSCs after primary clonal selections ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Notably, expression levels of telomerase genes *Tert* and *Terc* were already elevated by day 15 of induction and continued to increase to day 30, like those of the formed CiPSCs ([Figure 4](#fig4){ref-type="fig"}C). Thus telomerase genes are activated earlier than the pluripotent genes *Oct4*, *Sox2*, and *Nanog* ([Figures 4](#fig4){ref-type="fig"}B and 4C). The dynamics are consistent with those of conventional iPSC induction despite much less time required by OSKM-induced reprogramming ([@bib51]).Figure 4Telomere Dynamics during CiPSC Induction(A) Morphological changes of MEFs during chemical induction under bright field with phase contrast optics or Oct4-GFP fluorescence. Compact colonies were formed at day 40 of induction by three-step method, earlier than with the BrdU method. Scale bar represents 100 μm.(B) mRNA expression levels of *Oct4*, *Sox2*, *Nanog*, and *Zscan4* during chemical induction.(C) Relative expression levels of *Tert* and *Terc* during chemical induction.(D) Telomerase activity by TRAP assay of MEFs and reprogramming cells during induction, compared with CiPSCs at P4 or P5. Lysis buffer as negative control.(E) Telomere length distribution shown as TRF by Southern blot analysis during chemical induction (day 0--40) compared with CiPSCs. MW, molecular weight.(F) Immunofluorescence showing co-staining of γH2AX (green) at telomeres (TRF1, red). Yellow (white arrows) in merged images indicates co-localized foci of TRF1 and γH2AX. Scale bar represents 5 μm.(G) Quantification of TIFs. n = 100 cells counted.Data represent mean ± SEM from three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

However, expression levels of both *Tert* and *Terc* declined by day 40 of induction ([Figure 4](#fig4){ref-type="fig"}C). Correspondingly, telomerase activity was increased at day 15 and high at day 30 but decreased by day 40 ([Figure 4](#fig4){ref-type="fig"}D). In addition, TRF1 protein expression was gradually increased but also slightly reduced by day 40. TRF1 expression is increased during iPSC induction by the conventional method ([@bib42]). Moreover, levels of histone H3K9ac, H3K9me3, and H3K27me3 were increased at early stage of chemical induction, and H3K9ac and H3K27me3 were reduced at day 40 ([Figure S4](#mmc1){ref-type="supplementary-material"}B).

Telomeres maintained and elongated during the early to mid stage of chemical induction (days 0--30) ([Figure 4](#fig4){ref-type="fig"}E) coincided with increased telomerase activity ([Figure 4](#fig4){ref-type="fig"}D). Unexpectedly, telomeres shortened during the late stage of CiPSC induction (days 30--40), when the telomerase activity also was decreased ([Figure 4](#fig4){ref-type="fig"}D). These outcomes prompted us to investigate whether reprogramming cells undergo telomere damage after prolonged induction by examining telomere dysfunction-induced damage foci (TIFs) indicated by co-localized foci of phosphorylated H2AX with TRF1 at telomeres ([@bib8], [@bib46]). Indeed, co-localized foci of γH2AX and TRF1 were increased by day 40, and the proportion of the cells exhibiting more than 20 γH2AX foci also was elevated ([Figures 4](#fig4){ref-type="fig"}F and 4G). Thus, DNA and telomere damage may occur during the late stage of extended induction.

Few apoptotic cells were found on day 0 and day 15, but number of apoptotic cells with fragmented nuclei increased from day 30 to day 40 ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D). These data suggest that reduced telomerase, increased telomere damage, and apoptosis together may be responsible for the telomere erosion during prolonged periods of chemical induction, and this can limit CiPSC formation.

Histone Crotonylation Activates *Zscan4* and Maintains Telomeres during Chemical Induction {#sec2.6}
------------------------------------------------------------------------------------------

*Zscan4* is not effectively activated during chemical induction until in the formed CiPSCs following passages ([Figures 4](#fig4){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}B), like conventional iPSC induction ([@bib51]). Forced expression of *Zscan4*, in combination with Yamanaka factors, greatly reduces DNA damage response, and increases telomere elongation and quality of iPSCs ([@bib27]). Heterochromatic histone assembly, such as HP1 and H3K9me3 at telomeres/sub-telomeres, can regulate *Zscan4* expression (reviewed by [@bib30]). We searched for a variety of histone modification by small molecules, including trichostatin A, valproic acid, and sodium butyrate, that can activate *Zscan4* expression in mESCs ([@bib8], [@bib9]), but none of them can effectively activate *Zscan4* during chemical induction (data not shown). Excitingly, we found that a chemical compound, crotonic acid ([Figure S5](#mmc1){ref-type="supplementary-material"}A), which mediates lysine crotonylation (Kcr) ([@bib47], [@bib52], [@bib53]), can induce protein epigenetic modification and force *Zscan4* expression. Initially, mESCs were treated with 5 mM or 10 mM crotonic acid ([Figure S5](#mmc1){ref-type="supplementary-material"}B). 2C genes, including *Zscan4*, *Tcstv1*, and *Tcstv3*, were rapidly upregulated following two passages ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D), while genes for pluripotency (*Oct4*, *Sox2*, and *Nanog*) and telomerase *Tert* were downregulated ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). Proportion of Zscan4^+^ cells also was increased ([Figure S5](#mmc1){ref-type="supplementary-material"}E). Moreover, level of histone lysine crotonylation (Kcr), rather than other histone modifications (e.g., H3K27me3, H3K9me3, or H3K9ac), was elevated ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5F).

Further, we tested whether crotonic acid could also activate *Zscan4* during chemical induction ([Figure 5](#fig5){ref-type="fig"}A). Initially, MEFs were treated with crotonic acid or vehicle controls for the whole period of induction using the three-step method because of its higher induction efficiency ([Figure S1](#mmc1){ref-type="supplementary-material"}B), and were examined for colonies positive for Oct4-GFP fluorescence by the end of induction. Number of Oct4-GFP-positive colonies was not affected by crotonic acid. Then, we treated MEFs with crotonic acid at various periods, illustrated in [Figure 5](#fig5){ref-type="fig"}A, and observed that only the treatment for the period of stage II (days 16--28) effectively promoted Oct4-GFP colony formation. The Oct4-GFP colonies increased 3-fold in crotonic acid-treated-cells compared with non-treated cells ([Figures 5](#fig5){ref-type="fig"}A, 5B, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B). Expression of *Oct4*, *Nanog*, *Sox2*, *Lin28*, and *Terc* and *Tert* was not affected by crotonic acid during induction ([Figures 5](#fig5){ref-type="fig"}F and [S6](#mmc1){ref-type="supplementary-material"}C), consistent with telomerase activity ([Figure 5](#fig5){ref-type="fig"}C). Remarkably, addition of crotonic acid from day 16 resulted in ZSCAN4 activation by day 28 ([Figures 5](#fig5){ref-type="fig"}D--5F and [S6](#mmc1){ref-type="supplementary-material"}D). Histone lysine crotonylation (Kcr) was increased by crotonic acid treatment, while H3K9ac, H3K27me3, and H3K9me3 levels were not changed ([Figures 5](#fig5){ref-type="fig"}F and [S6](#mmc1){ref-type="supplementary-material"}D). 2C genes TCSTV1/3, which can elongate telomeres in mESCs ([@bib57]), also were upregulated after crotonic acid treatment ([Figure 5](#fig5){ref-type="fig"}F).Figure 5Crotonic Acid Addition at Stage II Activates *Zscan4*, Maintains Telomeres, and Promotes CiPSC Generation(A) Durations of crotonic acid (7 mM) addition at different time points during chemical induction and assessment of Oct4-GFP-positive colonies on day 40. Left panel shows different time points during reprogramming. Stage I (SI) represents days 0--15; stage II (SII) represents days 16--28; stage III (SIII) represents days 29--40. Right panel shows number of Oct4-GFP-positive colonies on day 40; 100,000 cells were re-plated on day 12 following induction. ^∗∗∗^p \< 0.001, compared with control.(B) Morphology by phase contrast optics and Oct4-GFP fluorescence of primary CiPSC colonies on day 40 induced with or without crotonic acid (CA) at stage II. Scale bar represents 100 μm.(C) Telomerase activity by TRAP assay. Lysis buffer and ESCs served as negative and positive controls, respectively.(D) Immunofluorescence microscopy of ZSCAN4 and Kcr (lysine crotonylation) expression. Scale bar represents 10 μm.(E) Percentage of Zscan4-positive cells. Number of cells counted is shown above the bar.(F) Western blot analysis of protein levels. MEF and CiPSCs served as controls.(G) Telomere length distribution shown as TRF by Southern blot analysis.(H) Quantification of telomere length by TRF in three repeats using TeloTool ([@bib15]). ^∗^p \< 0.05.(I) Immunofluorescence of γH2AX (green) at telomeres (TRF1, red). Yellow foci in the merged images indicate TRF1-γH2AX co-localization. Scale bar represents 5 μm. Bottom panel, quantification of TIFs. n = 100 cells counted. ^∗∗^p \< 0.01, n.s., not significant.Data represent mean ± SEM from three independent experiments. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Consistently, addition of crotonic acid at stage II rapidly lengthened telomeres following *Zscan4* upregulation, compared with the control, and maintained telomeres at the late stage of induction ([Figures 5](#fig5){ref-type="fig"}G and 5H). In addition, number of γH2AX-positive cells did not differ at stage II between crotonic acid-treated and non-treated cells. However, co-localization foci (TIFs) of γH2AX and TRF1 were much reduced on day 28 by crotonic acid ([Figure 5](#fig5){ref-type="fig"}I).

These data suggest that addition of crotonic acid at stage II (days 16--28) promotes CiPSC generation. Crotonic acid activates *Zscan4*, reduces telomeric damage, and maintains telomere length during chemically induced reprogramming.

Crotonic Acid Activates 2C Genes and Increases T-SCE during Chemical Induction {#sec2.7}
------------------------------------------------------------------------------

To better understand the mechanisms underlying crotonic acid in facilitating chemically induced reprogramming, we performed RNA-seq analysis of cell samples by days 20, 24, and 28 without or with crotonic acid treatment. More genes were upregulated than downregulated in crotonic acid-treated cells compared with controls ([Figure 6](#fig6){ref-type="fig"}A). Numbers of differentially expressed genes gradually increased from day 20 to day 28 following induction ([Figure 6](#fig6){ref-type="fig"}A). These genes were enriched in regulation of cell differentiation, cell proliferation, and apoptosis ([Figure 6](#fig6){ref-type="fig"}B). RNA-seq data also verified that *Zscan4* was prominently upregulated at day 28 following addition of crotonic acid on day 16 ([Figures 6](#fig6){ref-type="fig"}A and [5](#fig5){ref-type="fig"}D--5F).Figure 6RNA-Seq Reveals Crotonic Acid-Induced Activation of 2C Genes(A) Scatterplots showing global differential gene expression profile (fold ≥ 2.0) of reprogramming cells on days 20--28 following treatment with CA in comparison with controls. Red, upregulated genes; green, downregulated genes in CA-treated cells. Average from two independent experiments.(B) Gene ontology analysis of differentially expressed genes in cells treated with crotonic acid, compared with controls.(C) Fisher\'s exact test between relatively upregulated differential genes at early embryo developmental stages from single-cell RNA-seq data ([@bib12]) and all 196 differential genes from our RNA-seq data (p adjusted \< 0.01).(D) Heatmap highlighting highly expressed 2C genes found in CA-treated cells compared with controls.(E) ChIP-qPCR analysis of H3K9me3 and HP1α abundance at *Zscan4*, *Chr13_subtel* (sub-telomere region of no. 13 chromosome), and *ERVK10c* loci following treatment with crotonic acid for 12 days during stage II of induction. β*-actin* served as negative control. Data represent mean ± SD from three independent experiments. ^∗^p \< 0.05.(F) Schematic diagram illustrating the process of CiPSC induction following addition of crotonic acid, which activates 2C genes including Zscan4, reduces telomere and DNA damage, and maintains telomeres, promoting CiPSC formation.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

We compared all 196 differentially expressed genes with single-cell RNA-seq data of mouse preimplantation embryos ([@bib12]). Interestingly, by clustering of the differentially expressed genes to those expressed at cleavage stage of early embryo development, these genes were significantly enriched in the 2C (2C) embryo (p = 1.90 × 10^−5^), compared with other early embryonic development stages from oocyte to inner cell mass (ICM) of blastocysts ([Figure 6](#fig6){ref-type="fig"}C). Most of the 36 2C genes overlapped with the single-cell RNA-seq data were upregulated during induction by day 24 and noticeably by day 28 ([Figure 6](#fig6){ref-type="fig"}D). Additional comparison of our RNA-seq data with those of 2C genes ([@bib34]) substantiated that 2C genes were gradually upregulated following addition of crotonic acid during stage II of chemical induction ([Figure S6](#mmc1){ref-type="supplementary-material"}E). The differentially expressed 2C genes and their gradual activation were further confirmed by qPCR ([Figure S6](#mmc1){ref-type="supplementary-material"}F). However, crotonic acid reduced cell proliferation during the stage II reprogramming period ([Figure S6](#mmc1){ref-type="supplementary-material"}G). To test whether crotonylation regulates local heterochromatic distribution at 2C gene regions, we performed a chromatin immunoprecipitation (ChIP)-qPCR experiment using H3K9me3 and HP1α antibodies and the primers specific for the promoter-proximal regions of *Zscan4* loci, sub-telomere of chromosome 13, and the *ERVK10c* locus ([@bib8], [@bib9]). Crotonylation decreased levels of H3K9me3 and HP1α at these loci following treatment with crotonic acid for 12 days ([Figure 6](#fig6){ref-type="fig"}E).

Moreover, crotonic acid increased the frequency of T-SCE at a level similar to that of CiPSCs, compared with untreated reprogramming cells at day 28 ([Figures S6](#mmc1){ref-type="supplementary-material"}H and S6I). Addition of crotonic acid in CiPSCs further increased the incidence of T-SCE ([Figures S6](#mmc1){ref-type="supplementary-material"}H and S6I). Increased ZSCAN4 expression levels are associated with higher frequency of T-SCE.

These data show that crotonic acid activates a series of 2C genes in the middle of chemical induction, and, together with crotonylation-mediated *Zscan4* activation, increases T-SCE and telomere maintenance, and promotes CiPSC generation ([Figure 6](#fig6){ref-type="fig"}F).

Crotonic Acid-Facilitated CiPSCs Possess High Pluripotency {#sec2.8}
----------------------------------------------------------

The question was whether CiPSCs generated by addition of crotonic acid exhibit normal pluripotency. We characterized the CiPSCs derived by addition of crotonic acid (CaCiPSCs). Continuous passaging of the CaCiPSC primary colonies achieved stable CiPSC lines with Oct4-GFP fluorescence resembling typical ESC colonies in morphology, with large nuclei and nucleoli and clear, compact clonal boundaries ([Figure 7](#fig7){ref-type="fig"}A). Importantly, the majority of CaCiPSCs maintained normal karyotypes ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Moreover, CaCiPSCs expressed multiple pluripotent markers (*Oct4*, *Nanog*, *Sox2*, *Lin28*, *Zscan4*, and SSEA1) and also the naive state markers *Stella*, *Prdm14*, *Rex1*, and *Tbx3* ([@bib39], [@bib50]), comparable with those of ESCs ([Figures S7](#mmc1){ref-type="supplementary-material"}B--S7D).Figure 7Generation and Characterization of CaCiPSCs Induced by Addition of Crotonic Acid at Stage II(A) Morphology under bright field with phase contrast optics and Oct4-GFP fluorescence of CiPSCs generated without CA and CaCiPSCs with CA. Scale bar represents 100 μm.(B) Scatterplots comparing transcriptome profile of CaCiPS1t from CA-treated cells, CiPS2t without CA treatment, OG4 ESCs, and MEFs. Parallel diagonal lines indicate 2-fold threshold.(C) Hierarchical clustering of transcriptome profile of MEFs, OG4 ESCs, CiPS1b, CiPS2t, CaCiPS1t, and CaCiPS4t.(D and E) Summary table showing efficiency of chimera generation from CaCiPSCs at mid and late passages following injection into four- to eight-cell albino embryos (D). Chimeras were initially identified by coat color (E) and confirmed by microsatellite genotyping.(F) Representative telomere FISH images. Blue, chromosomes stained with DAPI; green dots, telomeres.(G) Histogram displaying distribution of relative telomere length shown as TFU by telomere Q-FISH. Medium telomere length (green lines) is shown as mean ± SD above each panel.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

RNA-seq analysis revealed that the transcriptome profile of CaCiPS1t resembled that of ESCs (OG4), with a correlation coefficient (R^2^) of 0.979 but was quite different from that of MEF ([Figure 7](#fig7){ref-type="fig"}B). Expression levels of pluripotency genes, naive marker genes, and *Zscan4* did not differ between CaCiPSCs and ESCs. Expression profile of CaCiPS1t and CaCiPS4t also was very similar to that of CiPS2t, and expression levels of pluripotency genes and naive marker genes did not differ between CaCiPSCs and CiPSCs ([Figure 7](#fig7){ref-type="fig"}B). All CiPSCs clustered with ESCs but not with the progenitor MEF cells ([Figure 7](#fig7){ref-type="fig"}C). Moreover, two CaCiPS cell lines, CaCiPS4t and CaCiPS1t, preferentially clustered with ESC OG4, relative to CiPS2t and CiPS1b ([Figure 7](#fig7){ref-type="fig"}C).

Furthermore, we tested the developmental potency by injection of CaCiPSCs into four- or eight-cell embryos from Balb/c albino mice. Chimeras were obtained with high efficiency by coat color ([Figures 7](#fig7){ref-type="fig"}D and 7E). However, cell lines varied in their contribution to chimeras. For instance, CaCiPSC2t generated chimeras at a very low rate. Chimerism derived from CaCiPSC4t was high based on coat color and microsatellite genotyping ([Figures 7](#fig7){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}F). Although CaCiPSCs can contribute to gonad in the chimeras ([Figure S7](#mmc1){ref-type="supplementary-material"}F), they also failed to produce germline transmission following breeding of chimeras (n = 10) with albino ICR mice for more than two rounds.

We also measured telomere lengths of CaCiPSCs at early and advanced passages. We picked up primary CaCiPSC and CiPSC colonies derived at the same time from the same batch of OG2-MEFs and passaged them *in vitro*. Telomere lengths varied among the cell lines but generally were not elongated much at P5 compared with MEFs ([Figure S7](#mmc1){ref-type="supplementary-material"}E), and this may indicate heterogeneity of primary CiPSC clones. By Q-FISH, telomere lengths also were indistinguishable among CiPS1t, CiPS2t, CaCiPS1t, and CaCiPS2t at P5 ([Figures 7](#fig7){ref-type="fig"}F and 7G). Nevertheless, telomeres lengthened significantly in both CaCiPS cell lines with increasing passages from P5 to P15 (CaCiPS1t, from 46.00 ± 15.98 to 70.36 ± 23.13 telomere fluorescence units \[TFU\]; CaCiPS2t, from 42.18 ± 18.17 to 63.49 ± 19.08 TFU) ([Figure 7](#fig7){ref-type="fig"}G). Hence, CaCiPSCs manifested high pluripotency, in association with telomere rejuvenation with passages.

To further explore the effect on genome stability of BrdU or crotonic acid addition during chemical reprogramming, we performed the whole-exome sequencing analysis. We compared BrdU-treated MEF cells with control MEF cells following culture for 12 days simultaneously and did not observe somatic point mutations in protein-coding regions ([Tables S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). Moreover, we characterized the protein-coding region of six CiPSC lines by three induction methods that generated chimeras at single-nucleotide resolution. The number of point mutations of these CiPSCs was similar to what had been previously reported for iPSCs ([Figure S7](#mmc1){ref-type="supplementary-material"}G) ([@bib14]). The CiPS1b and CiPS7b (BrdU method) cell lines had slightly more point mutations in coding regions (13 and 29) than did CiPS2t and CiPS6t (three-step method, 12 and 9) and CaCiPS2t and CaCiPS4t (crotonic acid method, 17 and 9) lines ([Figure S7](#mmc1){ref-type="supplementary-material"}G, [Tables S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). These mutated genes, however, did not cluster in a specific functional pathway.

Discussion {#sec3}
==========

We show that telomeres of CiPSCs elongate with passages after clonal formation. Telomere elongation with increasing passage depends on both telomerase and recombination-based ALT mechanisms ([Figure 6](#fig6){ref-type="fig"}F). Moreover, CiPSCs express 2C genes including *Zscan4*, *Tcstv1/3*, and *MuERVL*, like ESCs. Successful generation of CiPSCs further supports the notion that reprogramming and rejuvenation of telomeres are intimately linked to somatic reprogramming to induction of pluripotency. However, telomere damage occurs and telomeres shorten at late stage during prolonged chemical induction. Crotonylation induced by crotonic acid activates 2C genes, notably *Zscan4*, and increases T-SCE, which maintains telomeres and reduces telomere damage during chemical induction, improving induction efficiency ([Figure 6](#fig6){ref-type="fig"}F).

Currently, the low efficiency in achieving Oct4-GFP fluorescence colonies and particularly the lengthy induction still limit CiPSC generation. *Oct4* expression levels are very low during induction and can only be seen at late stage by qPCR analysis. OCT4 protein levels are too low to be detected by western blot during induction compared with the formed CiPSCs. Importantly, *Oct4* distal enhancer activation indicates achievement of sufficient reprogramming and is essential for achieving a naive pluripotency network ([@bib3], [@bib11], [@bib13]). Notably, telomerase activates earlier than do pluripotency genes *Oct4* and *Sox2*. Early activation of telomerase might result from CHIR99021 used at high concentration (seven times more than routinely used), which activates Wnt/β-catenin. Wnt/β-catenin signaling in turn can directly activate telomerase ([@bib20]). Our data suggest that *Oct4* could be expressed in only a few cells, revealed by the distal Oct4-GFP fluorescence during the late stage of chemical induction, such that the protein level in a cell population is minimal by western blot. Thus, timing to activate *Oct4* becomes essential for further enhancing CiPSC induction.

Also, *Nanog* is not activated well during chemical induction until CiPSC clonal formation and passages ([Figure 6](#fig6){ref-type="fig"}F). Nanog mediates acquisition of both embryonic and induced pluripotency ([@bib44]). Moreover, biallelic expression of *Nanog* is required in the timely maturation of the ICM into a fully reprogrammed pluripotent epiblast ([@bib38]). Inhibiting Tgf-β signaling promotes the completion of reprogramming through induction of *Nanog* ([@bib26]), and *Nanog* overexpression can accelerate reprogramming ([@bib16]). Presumably, chemicals that can activate *Nanog* earlier likely increase CiPSC induction.

Unexpectedly, telomeres shorten, coincident with telomere damage, and incidence of apoptosis also is increased during the late stage of lengthy induction by pure chemicals ([Figure 6](#fig6){ref-type="fig"}F). Fewer cells are likely to be selected and survive during reprogramming induction. This is in contrast to conventional iPSCs induced by Yamanaka factors, by which telomeres continue to elongate or at least maintain their length without shortening during the induction period ([@bib51]). Thus, chemicals that can alleviate telomere damage and shortening during the late stage of induction would enhance CiPSC generation.

Activation of *Zscan4* during induction indeed reduces telomere damage and improves iPSC induction and quality ([@bib19], [@bib27]). We find that crotonylation facilitated by crotonic acid can activate 2C genes and increase T-SCE during induction and that increased expression of ZSCAN4 reduces telomere damage and improves telomere maintenance, increasing CiPSC induction efficiency ([Figure 6](#fig6){ref-type="fig"}F).

Our data suggest that crotonic acid activates *Zscan4* and 2C genes, likely by reducing heterochromatic histones (e.g., H3K9me3 and HP1α) at telomeres/subtelomeres. This is consistent with the findings that histone crotonylation accumulates with HP1γ ([@bib47]) and reduces HP1α at heterochromatin ([@bib53]), and reduction of H3K9me3 leads to activation of 2C genes at subtelomeres; e.g., *Zscan4* and *Tcstv1* ([@bib8], [@bib9]). More experiments are needed to understand whether crotonylation directly or indirectly regulates the processes. Additionally, histone crotonylation has critical and broad function as histone acetylation in transcription ([@bib52]). Moreover, crotonylation improves CiPSC clone formation at stage II during middle induction, implying that XEN state is primed for action by crotonic acid. Continuous treatment with crotonic acid is not needed after *Zscan4* activation. Likewise, forced expression of *Zscan4* is required only for the first few days of conventional iPSC formation ([@bib19]).

Telomere maintenance during induction is one of the key elements for successful reprogramming to pluripotency. Histone crotonylation by crotonic acid is one example that protects telomeres by activating 2C genes and *Zscan4* and increasing T-SCE-based ALT-like activity, as shown here. Human iPSCs and ESCs generated thus far have not been demonstrated to exhibit ALT-like mechanisms, unlike mouse ESCs/iPSCs. It is unclear whether this is related to the pluripotency status of ESCs/iPSCs, as presumably conventional human iPSCs/ESCs are more like mouse epiblast stem cells or primed states than naive mouse iPSCs/ESCs ([@bib30]).

We anticipate that fine-tuning of treatment time and concentration of crotonic acid in combination with other chemicals that can facilitate early activation of *Oct4* distal enhancer and promoter and of *Nanog* may accelerate the reprogramming and improve CiPSC induction.

Experimental Procedures {#sec4}
=======================

Mice and Cell Culture {#sec4.1}
---------------------

Mice were housed and cared for in the College Animal Facility and the use of mice was approved by the Institutional Animal Care and Use Committee at Nankai University. All the animal experiments were performed following the ethical guidelines approved by the Tianjin Animal Management Committee. ESCs were cultured on mitomycin C-inactivated MEF feeder cells in the ESC medium, which was changed daily, and cells routinely passaged every 2 days. For culture of CiPSCs, 2i (3 μM CHIR99021 and 1 μM PD0325901) were added to the medium. The ESC culture medium consisted of knockout DMEM (Invitrogen) with 20% FBS (Hyclone), 1000 U/mL mouse leukemia inhibitory factor (LIF; ESG1107; Millipore), 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol, 1 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 μg/mL).

CiPSC Induction from MEFs {#sec4.2}
-------------------------

MEFs were isolated from OG2 mice. Isolated OG-MEF cells at early passages (up to P3) were used for chemical induction following the method described ([@bib59]). The details are described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Library Preparation and RNA Sequencing {#sec4.3}
--------------------------------------

A total amount of 3 μg of RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using NEBNext Ultra RNA Library Prep Kit for Illumina (NEB, United States) following manufacturer\'s recommendations and index codes were added to attribute sequences to each sample. More details are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Differential Gene Expression Analysis {#sec4.4}
-------------------------------------

For DESeq with biological replicates, differential expression analysis of two groups (two biological replicates per condition) was performed using the DESeq R package (1.18.0). More details are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

ChIP-qPCR Analysis {#sec4.5}
------------------

ChIP-qPCR analysis was performed as described previously ([@bib8], [@bib9]).

More methods are detailed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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